Advertisement

Organisation › Details
ImaBiotech Corporation
ImaBiotech is a Contract Research Organization (CRO) with facilities in Boston (MA, USA) and Lille (Eurasanté Parc, France). The company offers innovative services and software to the pharmaceutical research sector, providing highly in vivo informative drug efficacy and toxicity evaluations during preclinical and clinical stage developments at cellular level, making better and safer drugs. Services are based on histology combined to label free molecular imaging (Quantitative Mass Spectrometry Imaging, QMSI) a technology developed and constantly improved by ImaBiotech. QMSI is a game changer for the pharmaceutical industry in all therapeutic areas. While other techniques provide global information, this molecular technique provides a deeper understanding of a drugs localization and its pharmacological effects at cellular level. This improves the interpretation of drug efficacy and toxicity, resulting in better drugs and decreasing time-to-market. *
![]() |
Start | 2016-03-21 existent |
Group | ImaBiotech (Group) | |
![]() |
Industry | mass spectrometry software (MS software) |
Industry 2 | Quantinetix™ software for quantitative MALDI imaging | |
![]() |
Region | Cambridge, MA |
Country | United States (USA) | |
Street | 185 Alewife Brook Parkway | |
City | 02138 Cambridge, MA | |
Tel | +1-857-777-6764 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for �About Section�: ImaBiotech S.A.S.. (1/17/19). "Press Release: OCR and ImaBiotech Initiate a Strategic Partnership to Provide in situ Drug Efficacy and Target Exposure Services in Pets with Naturally Occuring Tumors". Lille. | ||
Record changed: 2019-07-13 |
Advertisement

More documents for ImaBiotech (Group)
- [1] ImaBiotech S.A.S.. (1/17/19). "Press Release: OCR and ImaBiotech Initiate a Strategic Partnership to Provide in situ Drug Efficacy and Target Exposure Services in Pets with Naturally Occuring Tumors". Lille....
- [2] ImaBiotech S.A.S.. (1/17/19). "Press Release: Metabrain Research and ImaBiotech Initiate a Strategic Partnership to Offer Cuttingedge Preclinical Research Services in Metabolic Disorders". Lille....
- [3] ImaBiotech S.A.S.. (6/13/16). "Press Release: Mass Spectrometry Imaging (MSI) Award 2016". Lille....
- [4] ImaBiotech S.A.S.. (4/14/16). "Press Release: ImaBiotech Signs License Agreement with Lawrence Berkeley National Laboratory". Lille & Berkeley, CA....
- [5] ImaBiotech S.A.S.. (3/29/16). "Press Release: ImaBiotech’s First Worldwide Patent Has Been Granted for Its Quantification Innovation in MSI". Lille....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top